Organon (OGN) Dividends Paid - Common (2021 - 2026)
Organon (OGN) posted quarterly Dividends Paid - Common of $5.0 million for Q1 2026, down 92.96% year-over-year from $71.0 million in Q1 2025, and up 25.0% on a QoQ basis from $4.0 million in Q4 2025.
Organon (OGN) Dividends Paid - Common (2021 - 2026) Analysis & Trends
Organon (OGN) has reported Dividends Paid - Common for 6 consecutive years, with $5.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Dividends Paid - Common fell 92.96% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $22.0 million (down 92.62% YoY), while the FY2025 annual figure was $88.0 million, down 70.37% from the prior year.
- Dividends Paid - Common came in at $5.0 million for Q1 2026 at Organon, up from $4.0 million in the prior quarter.
- The five-year high for Dividends Paid - Common was $79.0 million in Q2 2024, with the low at $3.0 million in Q3 2025.
- Average Dividends Paid - Common over 5 years is $57.3 million, with a median of $73.0 million recorded in 2022.
- Across the five-year window, Dividends Paid - Common increased 6.76% in 2024 and tumbled 95.95% in 2025, its largest moves.
- Year by year, Dividends Paid - Common stood at $73.0 million in 2022, then changed by 0.0% to $73.0 million in 2023, then advanced by 1.37% to $74.0 million in 2024, then sank by 94.59% to $4.0 million in 2025, then gained by 25.0% to $5.0 million in 2026.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $5.0 million, $4.0 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.55 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 3.13 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.09 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -3.29 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Organon | 3.53 Bn | 2.41 Bn | 783.00 Mn | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 71.00 Mn |
| Mar 31, 2025 | 71.00 Mn |
| Dec 31, 2024 | 74.00 Mn |
| Dec 31, 2024 | 74.00 Mn |
| Sep 30, 2024 | 74.00 Mn |
| Sep 30, 2024 | 74.00 Mn |
| Jun 30, 2024 | 79.00 Mn |
| Jun 30, 2024 | 79.00 Mn |
| Mar 31, 2024 | 70.00 Mn |
| Mar 31, 2024 | 70.00 Mn |
| Dec 31, 2023 | 73.00 Mn |
| Dec 31, 2023 | 73.00 Mn |